18. Genetics of breast cancer
- PMID: 12469982
18. Genetics of breast cancer
Abstract
It is well known that breast cancer often occurs in clusters within families. This clustering can be attributed to mutations in the breast cancer susceptibility genes, BRCA1 and BRCA2, in 16% of familial cases. Women with a family history of breast cancer, in whom no mutation is identified, are still at increased risk of developing the disease. This review addresses methods for estimating and stratifying risk of developing breast cancer based on family history. It also indicates how to identify patients likely to carry mutations in BRCA1 or BRCA2 and gives recommendations for intervention for women with a family history of breast cancer.
Similar articles
-
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145
-
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.Eur J Cancer. 2006 May;42(8):1143-50. doi: 10.1016/j.ejca.2005.11.032. Epub 2006 Apr 27. Eur J Cancer. 2006. PMID: 16644204
-
Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.J Clin Oncol. 2003 May 1;21(9):1675-81. doi: 10.1200/JCO.2003.09.052. J Clin Oncol. 2003. PMID: 12721241
-
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. J Gynecol Obstet Biol Reprod (Paris). 2003. PMID: 12717301 Review. French.
-
[BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].Lakartidningen. 2004 Jun 17;101(25):2172-7. Lakartidningen. 2004. PMID: 15281304 Review. Swedish.
Cited by
-
Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.Fam Cancer. 2012 Sep;11(3):483-91. doi: 10.1007/s10689-012-9540-8. Fam Cancer. 2012. PMID: 22692731
-
Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells.Oncol Lett. 2021 Feb;21(2):155. doi: 10.3892/ol.2020.12416. Epub 2020 Dec 31. Oncol Lett. 2021. PMID: 33552273 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous